Sphera Funds Management Ltd. Insmed Inc Transaction History

Sphera Funds Management Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$22.0 - $69.71 $364,958 - $1.16 Million	16,589 New	16,589 $1.11 Million
Q4 2017 Feb 12, 2018	SELL	$26.43 - $31.78 $3.57 Million - $4.29 Million	-135,000 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$11.61 - $31.21 $1.57 Million - $4.21 Million	135,000	135,000 $4.21 Million

467

182M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.48B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.